Thursday, April 3, 2025
4/3/2025
The Transmembrane Protein Disulfide Isomerase TMX1 Negatively Regulates Thrombosis - The control of platelet function and coagulation is a fine balance between activation and inhibitory mechanisms. Platelets become rapidly activated by multiple receptors agonists and have a central role in thrombosis in acute coronary syndromes, and other disease states. Similarly, naturally occurring anticoagulants are critical in preventing fibrin generation and thrombosis. Fivemembers of theprotein disulfide isomerase (PDI) family of enzymes, PDI, ERp57, ERp5, ERp72 and ERp46 potentiate activation of IIb3 and thrombosis.We discovered atransmembrane member of the PDI family found to inhibit activation of IIb3 and member of the PDI family in platelets, TMX1, which thrombosis. TMX1 is the first acts by a novel mechanism of oxidizing thiols to disulfide bonds and is the last checkpoint inhibitor of the platelet activation pathways that lead to conformational changes in IIb3 and fibrinogen binding. The prothrombotic PDIs are secreted from platelets and endothelial cells and support fibrin generation at the site of vascular injury. We found that TMX1 is expressed on platelets and endothelial cells but, negatively procoagulant in contras to the other PDIs, TMX1 regulates fibrin generation. One mechanism by which TMX1 inhibits coagulation is by limiting the effect of endothelial cells and platelets. We propose to study t vascular TMX1 as a dual negative regulator of platelets and coagulation by addressing the following Specific Aims. We will characterize 1. the role of TMX1 in thrombus formation; 2. the mechanism of inhibition of IIb3 activation by TMX1; 3. the effect of TMX1 on the other platelet PDIs, and on other platelet surface substrates. A principal technique used will be the laser-induced injury model of thrombosis. We will study the mechanism by which TMX1 negatively regulates coagulation. To determine the underlying mechanisms by which TMX1 inhibits platelet function we will integrate a platelet knockout mouse model with mass spectrometry-based identification of functional cysteines. This proposal will determine the mechanisms by which TMX1 works, and how TMX1 counterbalances the PDI enzymes that support activation of IIb3. Characterization of the negative regulatory role of TMX1 will provide novel insight into how the network of PDI enzymes regulate thrombosis. Studies on how TMX1 maintains the balance between thrombosis and hemostasis will elucidate optimal ways to promote hemostasis and inhibit thrombosis and provide a basis for studying TMX1 in disease states.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).